Sign In
Buy ADPT
$15.99
+0.85 (+5.61%)
At Close: Jun 03, 2026
Has Adaptive Biotechnologies (ADPT) Outpaced Other Medical Stocks This Year?
10:41am, Friday, 08'th Aug 2025
Here is how Adaptive Biotechnologies (ADPT) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Aristotle Focus Growth Q2 Highlights: Top Performers, Surprises And Strategic Shifts
06:05am, Friday, 08'th Aug 2025
Adaptive Biotechnologies and Netflix were top contributors, driven by strong earnings, momentum in core businesses, and positive outlooks. UnitedHealth Group and Visa detracted from performance due to
Why Adaptive Biotechnologies Stock Popped by Almost 6% on Wednesday
07:01pm, Wednesday, 06'th Aug 2025
Just after market close, Adaptive Biotechnologies (ADPT 5.97%) took the wraps off its second quarter. The following day, investors reacted to this by bidding the biotech company's stock up by almost 6
Adaptive (ADPT) Q2 Revenue Surges 36%
01:57pm, Wednesday, 06'th Aug 2025
Adaptive (ADPT) Q2 Revenue Surges 36%
Adaptive Biotechnologies Corporation (ADPT) Q2 2025 Earnings Call Transcript
02:13am, Wednesday, 06'th Aug 2025
Adaptive Biotechnologies Corporation (NASDAQ:ADPT ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Chad M. Robins - Co-Founder, CEO & Chairman Karina Calzadilla - Vice
Here's What Key Metrics Tell Us About Adaptive Biotechnologies (ADPT) Q2 Earnings
08:30pm, Tuesday, 05'th Aug 2025
While the top- and bottom-line numbers for Adaptive Biotechnologies (ADPT) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key m
Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Beats Revenue Estimates
07:01pm, Tuesday, 05'th Aug 2025
Adaptive Biotechnologies (ADPT) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to a loss of $0.26 per share a year ago.
Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results
04:05pm, Tuesday, 05'th Aug 2025
SEATTLE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the gen
Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025
04:05pm, Tuesday, 15'th Jul 2025
SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune syst
Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?
10:40am, Friday, 04'th Jul 2025
Here is how Adaptive Biotechnologies (ADPT) and Anavex Life Sciences (AVXL) have performed compared to their sector so far this year.
Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR®
07:30am, Tuesday, 01'st Jul 2025
clonoSEQ® is now integrated into Flatiron Health's OncoEMR®, simplifying MRD testing access for over 4,500 clinicians across the Flatiron network.
Adaptive Biotechnologies (ADPT) Surges 12.5%: Is This an Indication of Further Gains?
10:51am, Thursday, 26'th Jun 2025
Adaptive Biotechnologies (ADPT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in t
What Makes Adaptive Biotechnologies (ADPT) a New Buy Stock
01:01pm, Friday, 13'th Jun 2025
Adaptive Biotechnologies (ADPT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?
10:46am, Wednesday, 11'th Jun 2025
Here is how Adaptive Biotechnologies (ADPT) and CVS Health (CVS) have performed compared to their sector so far this year.
SEATTLE, May 30, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune syste
